{"id":212170,"name":"FERRING PHARMACEUTICALS","slug":"ferring-pharmaceuticals","state":"NJ","country":"United States of America","description":"biopharmaceuticals","totalSpending":606000,"filings":11,"yearlySpending":[{"year":2021,"income":240000},{"year":2022,"income":200000},{"year":2023,"income":166000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"FAM","display":"Family issues/Abortion/Adoption"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"DEF","display":"Defense"}],"firms":["THE MADISON GROUP"],"lobbyists":["MARCUS MASON","TIFFANY SHACKELFORD","DAVID YOUNGBLOOD","AYSHIA CONNORS","GLADYS BARCENA","CHYNA MELTON","MARISSA LORENZETTI"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Executive Office of the President (EOP)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues pertaining to maternal health and infertility","Issues pertaining to maternal health and infertility access and treatment","Issues pertaining to maternal health and infertility access and treatment\nHR 4450 - Access to Infertility Treatment and Care Act\nH. Res. 338 - Recognizing that infertility is a widespread problem that","Issues pertaining to maternal health and infertility access and treatment\nHR 4450 - Access to Infertility Treatment and Care Act\nH. Res. 338 - Recognizing that infertility is a widespread problem that","issues pertaining to maternal health and infertility access and treatment HR 4450/S.2352 - Access to Infertility Treatment and Care Act H. Res. 338 - Recognizing that infertility is a widespread probl"]}